Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Biocon Limited
Biocon Limited
Philogen S.p.A.
Bristol-Myers Squibb
Qingdao Sino-Cell Biomedicine Co., Ltd.
Second Life Therapeutics
Aura Biosciences
Onchilles Pharma Inc
Alpha Tau Medical LTD.
AccSalus Biosciences, Inc.
OncoHost Ltd.
Kyowa Kirin Co., Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Biotroy Therapeutics
Ankyra Therapeutics, Inc
Boston Immune Technologies and Therapeutics
Oncodesign Precision Medicine
Rapa Therapeutics LLC
Xynomic Pharmaceuticals, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Power Life Sciences Inc.
Power Life Sciences Inc.